Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
RaySearch Laboratories AB ( ($SE:RAY.B) ) just unveiled an announcement.
RaySearch Laboratories announced that board member Günther Mårder has resigned from the board with immediate effect for personal reasons, prompting a revision of shareholder proposals ahead of the company’s annual general meeting on May 7, 2026. Shareholders representing about 54 percent of voting rights now propose a four-member board without deputies, total board fees of SEK 1.44 million with SEK 840,000 allocated to the chairman and SEK 300,000 to each other member, and the re-election of Carl Filip Bergendal, Johan Löf, Britta Wallgren and Hans Wigzell, with Wigzell continuing as chairman, signaling continuity in governance despite the sudden departure.
More about RaySearch Laboratories AB
RaySearch Laboratories AB is a Swedish medical technology company specializing in innovative software for advanced cancer treatment. Its portfolio includes the RayStation treatment planning system, the RayCare oncology information system, and newer platforms such as RayIntelligence for oncology data analytics and RayCommand for treatment control, serving more than 1,200 clinics in 51 countries.
YTD Price Performance: -3.60%
Average Trading Volume: 174,723
Technical Sentiment Signal: Buy
Current Market Cap: SEK7.54B
For a thorough assessment of RAY.B stock, go to TipRanks’ Stock Analysis page.